Brought to you by

AbbVie, Johns Hopkins ally in five-year oncology deal
06 Dec 2016
Executive Summary
Under a five-year deal, AbbVie Inc. and Johns Hopkins University School of Medicine are teaming up to develop new cancer therapies.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com